JANINA KORBA: Open Payments
NPI 1598388688 · WINDSOR, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 29 payments from 8 companies in 2025. Trend: 2023 $20 · 2024 $310 · 2025 $1,163
Food & beverage: $1,063Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $379 |
| GENZYME CORPORATION | 7 | $291 |
| Janssen Biotech, Inc. | 6 | $185 |
| Lilly USA, LLC | 1 | $117 |
| ABBVIE INC. | 1 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| UCB, Inc. | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: DUPIXENT, TREMFYA, COSENTYX, EBGLYSS, Rhapsido, SKYRIZI, AYVAKIT, Bimzelx.
Industry payments across CO — which companies pay providers there.
